Share on StockTwits

Solazyme (NASDAQ:SZYM) CFO Tyler Painter sold 10,000 shares of Solazyme stock on the open market in a transaction dated Wednesday, August 13th. The stock was sold at an average price of $9.17, for a total transaction of $91,700.00. Following the completion of the transaction, the chief financial officer now directly owns 413,249 shares in the company, valued at approximately $3,789,493. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.

Solazyme (NASDAQ:SZYM) traded down 0.87% during mid-day trading on Friday, hitting $9.15. 568,326 shares of the company’s stock traded hands. Solazyme has a one year low of $8.00 and a one year high of $15.00. The stock’s 50-day moving average is $10.09 and its 200-day moving average is $11.01. The company’s market cap is $720.1 million.

Solazyme (NASDAQ:SZYM) last posted its quarterly earnings results on Wednesday, July 30th. The company reported ($0.43) EPS for the quarter, missing the Thomson Reuters consensus estimate of ($0.36) by $0.07. The company had revenue of $15.94 million for the quarter, compared to the consensus estimate of $17.13 million. During the same quarter in the prior year, the company posted ($0.28) earnings per share. The company’s quarterly revenue was up 42.6% on a year-over-year basis. On average, analysts predict that Solazyme will post $-1.71 earnings per share for the current fiscal year.

Separately, analysts at Morgan Stanley reiterated an “overweight” rating on shares of Solazyme in a research note on Friday, May 30th. They now have a $15.00 price target on the stock. One research analyst has rated the stock with a hold rating and one has given a buy rating to the stock. The company currently has a consensus rating of “Buy” and a consensus target price of $15.00.

Solazyme, Inc operates as a renewable oil production company. The Company fuels include microbial-derived jet fuels, bio-diesels, and renewable diesels.

Receive News & Ratings for Solazyme Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Solazyme Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.